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In the present study, we investigated whether treatment with GBCK25 facilitated the recovery of he-
modynamic parameters, left ventricle systolic pressure, left ventricular developed pressure, and elec-
trocardiographic changes. GBCK25 signiﬁcantly prevented the decrease in hemodynamic parameters and
ameliorated the electrocardiographic abnormality. These results indicate that GBCK25 has distinct car-
dioprotective effects in rat heart.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Ginseng root, as an herbal medicine, has beenwidely used in the
Orient for thousands of years [1,2]. In the present study, the pro-
tective effect of ginseng fermented with new strain Saccharomyces
servazzii GB-07 and pectinase enzyme (GBCK25) on the ischemiae
reperfusion (I/R) injury in an isolated rat heart was evaluated [3e5].
GBCK25was kindly obtained by General Bio Co., Ltd. (Generalbio
Co, Jeollabuk-do, Korea) using a standardized process. Namely, the
procedure was conducted using complex fermentation combined
with new strain Saccharomyces servazzii GB-07 and pectinase
enzyme for 5 d to convert general ginsenoside into Compound K.
The contents of ginsenosides in GBCK25 were composed of ginse-
noside Rg1, 26.74 mg/g; Re, 62.15 mg/g; Rh1(s) þ Rg2(s), 14.93 mg/
g; Rb1, 3.22 mg/g; Rc, 4.38 mg/g; Ra1, 5.67 mg/g; Rb2, 26.76 mg/g;
Rb3, 3.83 mg/g; Rd, 14.61 mg/g; Rg3(s), 6.23 mg/g; CK, 23.22 mg/g;
and other minor components. GBCK25 was dissolved in a modiﬁed
Krebs-Henseleit (KH) buffer which consisted of 120.0mM NaCl,
1.2mMMgSO4, 4.8mMKCl,1.2mMKH2PO4, 25mMNaHCO3,11.0mM
glucose, and 25mM CaCl2. In this study, the reagents were pur-
chased from Sigma (St. Louis, MO, USA) and were of analytical
grade.
The study was conducted using 35 male Sprague-Dawley rats
weighing 200 20 g. All the animals were obtained from SLC Inc.icine, Biosafety Research Institute,
.
ht  2016, The Korean Society of G
d/4.0/).(Shizuoka, Japan). The Principles of Laboratory Animal Care were
followed in accordance with the “Guideline for Institutional Animal
Care and Use Committees” of Chonbuk National University (Jeonju,
Korea).The Sprague-Dawley rat hearts were perfused for a total of
180 min. This perfusal consisted of a pre-ischemia period (i.e.,
equilibration for 30 min, followed by 60 min ischemia, and 120 min
reperfusion at 37C (Fig. 1). The hearts were divided into ﬁve
experimental groups (n¼ 7, each group). In the normal control (N/
C) group, hearts were perfused with KH buffer without ischemia. In
GBCK25 control, hearts were perfused with buffer for 30 min, and
perfusion was followed for 60 min plus 120 min without ischemia.
In the I/R group, hearts were perfused with buffer for 30 min, fol-
lowed by 60 min ischemia and 120 min reperfusion. In the 200 mg/
kg and 400 mg/kg GBCK25 groups, hearts were perfused with
buffer for 30 min, followed by 60 min of ischemia and 120 min
reperfusion, respectively (Fig. 1). After pretreatment with 200 mg/
kg and 400 mg/kg GBCK25 for 7 d, the rats were anesthetized with
25e30 mg of pentobarbital intraperitoneally. Hearts were excised
and were immersed in 4C solution to prevent myocardial damage.
After the hearts were stabilized for 30 min, ischemia was induced
for 60 min. The hemodynamic data such as perfusion pressure,
coronary ﬂow, aortic ﬂow, and cardiac output andChonbuk National University, 79, Gobong-ro, Ikdan-si, Jeollabuk-do 54596, Korea.
inseng, Published by Elsevier. This is an open access article under the CC BY-NC-ND
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Fig. 1. All experimental groups began with a 30-min perfusion period to allow for
stabilization. Then, the hearts were divided into the normal control (N/C) group, the
GBCK25 alone treated group (GBCK25), the 60 min ischemia and 120 min reperfusion
group (I/R control), the 60 min ischemia and 120 min reperfusion, which received
administration of 200 mg/kg GBCK25 before ischemia induction (200GBCK25þI/R),
and the 60 min ischemia and 120 min reperfusion, which received administration of
400 mg/kg GBCK25 before ischemia induction (400GBCK25þI/R). ECG, electrocardio-
gram; I/R, ischemiaereperfusion.
A. Aravinthan et al / GBCK25 increased the cardiac functions against I/R injury 463electrocardiogram (ECG) parameters were studied. The developed
maximal rates of contraction (þdP/dtmax) and relaxation (dP/
dtmax) were recorded after 120 min reperfusion. Both þdP/dtmax
and dP/dtmax were studied as indices of cardiac contractility. All
statistics were calculated using SigmaPlot for Windows version
12.0 (Systat Software, Inc., USA). For all studies, signiﬁcance was
statistically considered at p< 0.05.
The effect of GBCK25 on the hemodynamics was assessed by
measuring cardiac function including coronary ﬂow, aortic ﬂow,
and cardiac output. These parameters were substantially decreased0 30 60 90 120 150 180 210
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Fig. 2. Effects of 200 mg/kg and 400 mg/kg GBCK25 between (A) aortic ﬂow, (B) coronary
dynamics. Each histogram represents the mean SD (n¼ 7). * p< 0.05 compared with I/R
reperfusion; N/C, normal control group.by I/R induction to an average of 66.374.92%, 69.514.65%, and
65.04 3.27% compared to an N/C group as 100%, respectively.
However, pretreatment with GBCK25 (200 mg/kg and 400 mg/kg)
increased coronary ﬂow, aortic ﬂow, and cardiac output to an
average of 72.68 4.79%, 73.24 5.02%, and 72.86 6.39%,
respectively, using 200 mg/kg GBCK25, and to an average of
82.42 5.31%, 81.374.17%, and 82.43 5.21%, respectively, using
400mg/kg GBCK25 (Fig. 2). Furthermore, I/R induction signiﬁcantly
decreased average left ventricle systolic pressure (LVSP) values;
69.6 3.2% (baseline), 68.74.1% (30 min), 66.5 4.6% (60 min),
66.4% (90 min), and 63.2 3.5% (120 min) compared to the N/C
group as 100 %, respectively.
In contrast, pretreatment with 200 mg/kg GBCK25 signiﬁcantly
increased LVSP values; 75.73.3% (baseline), 74.2 3.6% (30 min),
74.3 3.2% (60 min), 73.2 3.1% (90 min), and 73.13.5%
(120 min) compared to the N/C group as 100 %, respectively. Pre-
treatment with 400 mg/kg GBCK25 signiﬁcantly increased LVSP
values; 82.4 4.1% (baseline), 84.5 4.7% (30 min), 83.7 3.9%
(60min), 81.9 3.6% (90min), and 82.7 3.7% (120min) compared
to the N/C group as 100%, respectively (Fig. 3). Likewise, I/R in-
duction resulted in a signiﬁcant fall in average þdP/dtmax values to
52.9 3.75% for 120 min, whereas pretreatment with GBCK25
signiﬁcantly increased the average þdP/dtmax values to
63.69 4.74% in 200 mg/kg GBCK25, and 84.63 4.55% in 400 mg/
kg GBCK25 for 120 min, respectively (Fig. 4A). Under the same
conditions, the average dP/dtmax values were 62.75 3.63%
compared to the N/C group as 100% in the I/R group. However,
GBCK25 signiﬁcantly increased edP/dtmax values to an average of
69.65 3.52% in 200 mg/kg GBCK25, and 78.474.71% in 400 mg/
kg GBCK25 for 120 min, respectively (Fig. 4B). As seen in Figs. 2e4,0 30 60 90 120 150 180 210
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Fig. 3. Effects of 200 mg/kg and 400 mg/kg GBCK25 on left ventricle systolic pressure
left ventricle systolic pressure (LVSP). These hemodynamic parameters were estimated
at 30 min intervals throughout the 120-min reperfusion period. Results were repre-
sentative of nine independent experiments. Values are expressed as mean SD.
* p< 0.05. ** p< 0.01. I/R, ischemiaereperfusion; N/C, normal control group.
J Ginseng Res 2016;40:462e465464there was no difference between hemodynamics such as LVSP
and dP/dtmax between the N/C and the GBCK25 groups. These
results suggest that GBCK25 itself did not inﬂuence cardiac he-
modynamic function in the experiments.
In the ECG study, the normal group showed a normal ECG. No
signiﬁcant differences on conduction intervals for the GBCK25
group and the N/C group were observed as seen in Fig. 5. However,
when studying ECG parameters after 30 min ischemia and 120 min
reperfusion, the QRS interval tended to be signiﬁcantly delayed
compared to the N/C group (Fig. 5). In I/R control, an average of QRS
values was 138.24 5.22% for 120 min compared to the N/C group
(an average N/C value as 100). As shown in Fig. 5, animals in the I/R
group also produced the pathological R amplitude, showing
transmural cardiac infarction. However, the QRS interval signiﬁ-
cantly shortened in the 200 mg/kg and 400 mg/kg GBCK25-treated
groups compared to the I/R group for 120 min I/R induction.Fig. 4. Effects of 200 mg/kg and 400 mg/kg GBCK25 on (A) þdP/dtmax and (B) edP/dtmax. Th
min reperfusion period. Results were representative of nine independent experiments. Value
I/R. þdP/dtmax, maximal rate of contraction; edP/dtmax, maximal rate of relaxation; I/R, iscAverage values of QRS intervals were 130.714.95% for the
200 mg/kg GBCK25-treated group and 122.16 4.73% for the
400 mg/kg GBCK25-treated group compared to the I/R control
group for 120 min (Fig. 5). As shown in Fig. 5B, the 400 mg/kg
GBCK25-treated group was more effective than the 200 mg/kg
GBCK25-treated group (p< 0.5, p< 0.01). The results indicated that
treatment with 400 mg/kg GBCK25 is more effective than with
200 mg/kg GBCK25 in the preservation of atrioventricular con-
duction. In addition, in the GBCK25 control group, QT interval
alterationwas similar to the N/C group, as seen in Fig. 5C. Moreover,
I/R induction produced signiﬁcant delayed QT interval compared to
N/C animals. In the I/R control group, an average QT value is
136.37 5.22 % for 120 min when compared to the N/C group (an
average N/C value as 100%). For the 200 mg/kg and 400 mg/kg
GBCK25-treated groups, QT interval signiﬁcantly shortened
compared to the I/R group. Namely, the average values of QT in-
terval for 120 min were 129.18 4.52% for the 200 mg/kg GBCK25-
treated group and 123.513.73% for the 400 mg/kg GBCK25-
treated group. As shown in Fig. 5, the GBCK15 control group had
no signiﬁcant effectiveness in the QT interval study for total
180 min I/R periods (p> 0.5). The results indicated that treatment
with GBCK25 can be effective in the preservation of repolarization.
Also, it is known that heart rate interval is studied with the R to R
wave (RR) [6].
In the present study, a normal RR interval was obtained, similar
to the N/C group. However, in the I/R group, the RR interval tended
to be signiﬁcantly delayed compared to the N/C group. Compared to
the N/C group (N/C value as 100%), the I/R group had an RR interval
of 123.66 3.71% for 120 min reperfusion. These values were
changed when 200 mg/kg and 400 mg/kg GBCK25 were used as
shown in Fig. 5D. Namely, the RR intervals for 200 mg/kg and
400 mg/kg GBCK25-treated groups were 118.22 2.95% and
110.612.89%, respectively. These data were signiﬁcantly shorter
than the I/R control for 120 min reperfusion.
These results indicated that treatment with 200 mg/kg and
400mg/kg GBCK25 can be effective in the preservation of heart rate
in rats (Fig. 5D). Therefore, the present study provides a preliminary
possibility for the application of GBCK25. However, further studies
need to be carried out to give assurance that these results can be
used for humans. In the point of the safety and efﬁcacy of GBCK25,
prospective further studies should be considered.ese hemodynamic parameters were estimated at 30-min intervals throughout the 120-
s are expressed as mean SD. * p< 0.05 compared with I/R. ** p< 0.01 compared with
hemiaereperfusion; N/C, normal control group.
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Fig. 5. Effects of 200 mg/kg and 400 mg/kg GBCK25 on representative electrocardiogram tracings. (A) Enlarged ECG patterns such as QRS complex, QT, and RR intervals are shown
(shown in circle area on ECG of N/C lane). These pictures were representative ECG patterns in each group. Effects of 200 mg/kg and 400 mg/kg GBCK25 on (B) QRS, (C) QT, and (D) RR
intervals are shown. Values are expressed as mean SD for eight independent experiments in each group. * p< 0.05 compared with I/R. ** p< 0.01 compared with I/R. ECG,
electrocardiogram; I/R, ischemiaereperfusion; N/C, normal control group.
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